Attana AB-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Attana AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011788
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Attana AB (Attana) develops, manufactures and markets reagent kits and chip surfaces. The company offers products such as instruments, chip surfaces, reagents, kits and consumables; softwares, and accessories and spare parts. Its services comprise contract research, instrument training, attana demo, proof of principle studies, assay development services, service and support agreements; application support, attana in-house visits and technical support services. Its products are used in cell-based assay, biochemical assay, accessibility, off-target interaction, avidity, kinetics and affinity; crude sample analysis, serum sample analysis, sandwich pair selection, hybridoma screening and other applications. Attana is headquartered in Stockholm, Sweden.

Attana AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Attana AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Attana AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Attana AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Attana AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Attana AB, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Tecan Extends Distribution Agreement With Attana 9
Attana Enters Into Distribution Agreement With Layerlab For memLayer 10
Tecan Enters Into Distribution Agreement With Attana 11
Attana AB – Key Competitors 12
Attana AB – Key Employees 13
Attana AB – Locations And Subsidiaries 14
Head Office 14
Recent Developments 15
Government and Public Interest 15
Nov 16, 2017: Attana, Karoliniska Universitetssjukhuset and KTH receives project grant of 4.8 MSEK 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Attana AB, Pharmaceuticals & Healthcare, Key Facts 2
Attana AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Attana AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Attana AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Attana AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Attana AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Tecan Extends Distribution Agreement With Attana 9
Attana Enters Into Distribution Agreement With Layerlab For memLayer 10
Tecan Enters Into Distribution Agreement With Attana 11
Attana AB, Key Competitors 12
Attana AB, Key Employees 13

★海外企業調査レポート[Attana AB-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Shire plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Shire plc Mergers and Acquisiti …
  • Ampio Pharmaceuticals, Inc. (AMPE):企業のM&A・提携動向(医療機器分野)
    Summary Ampio Pharmaceuticals, Inc. (Ampio), formerly Chay Enterprises, Inc., is a biopharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company offers products for the treatment of osteoarthritis of the knee and for the treatment of diab …
  • Lechwerke AG (LEC):企業財務及び戦略的SWOT分析
    Summary Lechwerke AG (LechWerke) is an electric utility company that offers energy products and services to private, business and industrial customers. The company’s technology products include photovoltaic system, battery storage, RWE smarthome, multidivisional house connection, and LEW E-mobility. …
  • Rural Electrification Corporation Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Rural Electrification Corporati …
  • Aerowatt SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Aerowatt SA Mergers and Acquisi …
  • Aptiv Solutions, Inc.(製薬・医療分野):企業M&A動向
    Summary Aptiv Solutions, Inc. (Aptiv Solutions), a subsidiary of ICON plc is a contract research organization. The organization offers adaptive trials, medical device trials, conventional drug trials, consulting and monitoring services. It also offers medical device development and early phase devel …
  • Government of New Zealand:企業のM&A・提携動向(エネルギー分野)
    Summary Government of New Zealand (Govt.nz) is an administrative service provider that offers various utility and care services. The government provides services such as births, marriage and civil unions, ID and personal details, change of name, divorce and separation. It offers citizenship, funding …
  • Dynamix Pharmaceuticals Ltd.(製薬・医療分野):企業M&A動向
    Summary Dynamix Pharmaceuticals (Dynamix Pharma) is a pharmaceutical company. The company discovers and develops small molecule drugs for treating patients with cancer and autoimmune disorders. Its products under clinical development include PKM2, SYK, JAK3, FAK/PYK2 and PLK1. Dynamix Pharma’s JAK3 …
  • San Juan Basin Royalty Trust (SJT):企業財務及び戦略的SWOT分析
    Summary San Juan Basin Royalty Trust (SJT) is a trust that has overriding royalty interest divided out of Southland Royalty's oil and gas leasehold and royalty interest in the San Juan Basin of northwestern New Mexico. The trust’s underlying properties include working interests, overriding royalty i …
  • Softbrain Co., Ltd. (4779):企業の財務及び戦略的SWOT分析
    Summary Softbrain Co., Ltd. (Softbrain) is a technology company that develops, distributes and provides business management system and business process manager systems. The company’s products include e-sales manager, e-field service manager, e-business call manager, e-kotei manager, and e-somu manag …
  • Novatel Wireless, Inc. (NVTL):企業概要、財務及び戦略的SWOT分析
    Summary Novatel Wireless, Inc. (Novatel) is a wireless technology solutions provider. The company provides machine-to-machine products and solutions, and mobile computing products. Its mobile broadband portfolios include MiFi intelligent mobile hotspots, converged voice and data, USB modems, data ca …
  • RPG Itochu Finance Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' RPG Itochu Finance Limited Merg …
  • Guest-Tek Interactive Entertainment Ltd.:企業の戦略的SWOT分析
    Guest-Tek Interactive Entertainment Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • SteadyMed Therapeutics Inc:製品パイプライン分析
    Summary SteadyMed Therapeutics Inc (SteadyMed), a subsidiary of SteadyMed Ltd is a pharmaceutical company that develops and commercializes therapeutic product candidates. The company provides patchpump, a customizable, pre-filled, and pre-programmed disposable parenteral delivery platform for large …
  • Viralytics Ltd. (VLA)(製薬・医療分野):企業M&A動向
    Summary Viralytics Limited (Viralytics) is a biotechnology company. The company develops oncolytic virotherapy for the treatment of different types of cancers. Its products under clinical development include CAVATAK and EVATAK. Viralytics’s CAVATAK drug product is a therapeutic formulation of Coxsac …
  • Belvedere S.A.:企業概要・SWOT・財務分析
    Summary Canadean's "Belvedere S.A. : Consumer Packaged Goods - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business descripti …
  • Biosearch Life. (BIO):企業の財務及び戦略的SWOT分析
    Summary Biosearch S.A. (Biosearch) is a biotechnology company that develops and offers new solutions for various markets. The company offers products which include ingredients, probiotics, dried extracts, fluid extracts, and glycerinated extracts. Its products are used in infant nutrition, gut healt …
  • Banca Popolare di Sondrio Private Banking:企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Banca Popolare di Sondrio Private Banking" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. T …
  • Sanchez Energy Corporation (SN):企業概要、財務及び戦略的SWOT分析
    Summary Sanchez Energy Corporation (SEC) is an independent upstream oil and gas company. The company explores, develops and produces oil and natural gas from its assets in the Eagle Ford Shale in South Texas. It holds working interest in oil and condensate assets in Gonzales, Zavala, Frio, Fayette, …
  • Flextronics International Ltd. (FLEX):企業のM&A・提携動向(エネルギー分野)
    Summary Flextronics International Ltd. (Flextronics) is a provider of technology solutions. It designs, manufactures and provides supply chain services to original equipment manufacturers. The major solutions that the company offers include disposables, drug delivery, diagnostics devices, automotive …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆